More evidence links Lipitor with diabetes

While researchers have already linked the cholesterol drug Lipitor (atorvastatin) with a higher risk of type 2 diabetes, a new study "strengthens evidence of a connection," according to a Reuters report. However, this strong risk comes with other factors that, to some extent, patients could do something about--including excess weight, high blood sugar, elevated triglycerides and high blood pressure. These factors are "very good at distinguishing people at high or low risk for developing new-onset diabetes with atorvastatin," lead researcher Dr. David D. Waters, of the University of California at San Francisco, told Reuters Health. Article

Suggested Articles

Novartis is rolling out positive interim phase 3 data on Zolgensma in Europe, which could support the recent launch of the SMA gene therapy there.

The new cost-cutting goal comes on top of a €2.6 billion annual savings target the company already laid out in a revamp initiated in 2018.

As hearings continued on Capitol Hill, a congressional committee said Novartis, Amgen and Mallinckrodt used routine price hikes to meet sales targets.